Enzo Biochem (NYSE:ENZ) Releases Quarterly Earnings Results

Enzo Biochem (NYSE:ENZ) released its quarterly earnings data on Monday. The medical research company reported ($0.05) earnings per share for the quarter, Zacks reports. Enzo Biochem had a negative net margin of 81.73% and a negative return on equity of 11.84%.

Enzo Biochem Stock Performance

NYSE ENZ opened at $0.70 on Wednesday. Enzo Biochem has a fifty-two week low of $0.68 and a fifty-two week high of $1.50. The business has a 50 day moving average price of $1.09 and a two-hundred day moving average price of $1.11.

Enzo Biochem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, December 2nd. Investors of record on Friday, November 15th were issued a dividend of $0.10 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $0.40 annualized dividend and a dividend yield of 57.14%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on shares of Enzo Biochem in a research report on Tuesday. They issued a “hold” rating for the company.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.